Ophthalmic Drugs and Devices Market Research Report Information by Product (Drugs and Devices), by Treatment (Eye Infections, Allergic Conjunctivitis, Dry Eyes Syndrome, Red Eyes, Inflammation, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2032.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING PREVALENCE OF OPHTHALMIC DISORDERS

4.2.2 RISING GERAITRIC POPULATION

4.2.3 GROWING NUMBER OF DIABETES CASES

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS REGARDING EYE DISORDERS

4.3.2 SIDE EFFECTS ASSOCIATED WITH OPHTHALMIC DRUGS

4.4 OPPORTUNITIES

4.4.1 INCREASE PRODUCT DEVELOPMENT AND LAUNCHES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE OPHTHALMIC DRUGS AND DEVICES MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTION

5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 DRUGS

6.2.1 PILOCARPINE

6.2.2 MICROPINE

6.2.3 PROVISC

6.2.4 DIURETICS

6.2.5 VASOCONSTRICTORS

6.2.6 FLUOCINOLONE

6.2.7 BIMATOPROST

6.2.8 OTHERS

6.3 DEVICES

6.3.1 GLASSES AND CONTACT LENS

6.3.2 OPTICAL DISPENSER

6.3.3 EYE MASSAGERS

6.3.4 SPONGE DEVICES AND EYE CLEANER

6.3.5 OTHERS

7 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT

7.1 OVERVIEW

7.2 EYE INFECTIONS

7.3 ALLERGIC CONJUNCTIVITIS

7.4 DRY EYES SYNDROME

7.5 RED EYES

7.6 INFLAMMATION

7.7 OTHERS

8 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY REGION

8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 US

8.2.2 CANADA

8.3 EUROPE

8.3.1 GERMANY

8.3.2 UK

8.3.3 FRANCE

8.3.4 ITALY

8.3.5 SPAIN

8.3.6 REST OF EUROPE

8.4 ASIA-PACIFIC

8.4.1 JAPAN

8.4.2 CHINA

8.4.3 INDIA

8.4.4 AUSTRALIA

8.4.5 SOUTH KOREA

8.4.6 REST OF ASIA-PACIFIC

8.5 REST OF THE WORLD

8.5.1 MIDDLE EAST

8.5.2 AFRICA

8.5.3 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 COMPETITIVE BENCHMARKING

9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET

9.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET

9.5 KEY DEVELOPMENT ANALYSIS

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCH

9.6.2 COLLABORATION

9.6.3 AGREEMENT

9.6.4 ACQUISITION

9.7 MAJOR PLAYERS FINANCIAL MATRIX

9.7.1 SALES (USD MILLION), 2021

9.7.2 R&D (USD MILLION), 2021

10 COMPANY PROFILES

10.1 JOHNSON AND JOHNSON VISION

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL OVERVIEW

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 ALLERGAN PLC

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 TEVA PHARMACEUTICAL INDUSTRIES LTD.

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL ANALYSIS

10.3.3 PRODUCTS OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.3.6 KEY STRATEGIES

10.4 OCULAR THERAPEUTIX, INC

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 SWOT ANALYSIS

10.4.6 KEY STRATEGIES

10.5 BAUSCH & LOMB INCORPORATED

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 SWOT ANALYSIS

10.5.6 KEY STRATEGIES

10.6 SIGHT SCIENCES, INC.

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL ANALYSIS

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 KEY STRATEGIES

10.7 MIBO MEDICAL GROUP

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 KEY STRATEGIES

10.8 ALCON

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS 0FFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 SWOT ANALYSIS

10.8.6 KEY STRATEGIES

10.9 BIOTISSUE

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 KEY STRATEGIES

10.10 NUSIGHT MEDICAL

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES

11.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 4 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY REGION, 2018–2030 (USD MILLION)

TABLE 7 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR PILOCARPINE, BY REGION, 2018–2030 (USD MILLION)

TABLE 8 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR MICROPINE, BY REGION, 2018–2030 (USD MILLION)

TABLE 9 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR PROVISC, BY REGION, 2018–2030 (USD MILLION)

TABLE 10 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DIURETICS, BY REGION, 2018–2030 (USD MILLION)

TABLE 11 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR VASOCONSTRICTORS, BY REGION, 2018–2030 (USD MILLION)

TABLE 12 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR FLUOCINOLONE, BY REGION, 2018–2030 (USD MILLION)

TABLE 13 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR BIMATOPROST, BY REGION, 2018–2030 (USD MILLION)

TABLE 14 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 15 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY REGION, 2018–2030 (USD MILLION)

TABLE 16 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR GLASSES AND CONTACT LENS, BY REGION, 2018–2030 (USD MILLION)

TABLE 17 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OPTICAL DISPENSER, BY REGION, 2018–2030 (USD MILLION)

TABLE 18 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR EYE MASSAGERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 19 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR SPONGE DEVICES AND EYE CLEANER, BY REGION, 2018–2030 (USD MILLION)

TABLE 20 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 21 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 22 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR EYE INFECTIONS, BY REGION, 2018–2030 (USD MILLION)

TABLE 23 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR ALLERGIC CONJUNCTIVITIS, BY REGION, 2018–2030 (USD MILLION)

TABLE 24 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRY EYES SYNDROME, BY REGION, 2018–2030 (USD MILLION)

TABLE 25 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR RED EYES, BY REGION, 2018–2030 (USD MILLION)

TABLE 26 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR INFLAMMATION, BY REGION, 2018–2030 (USD MILLION)

TABLE 27 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 28 GLOBAL: OPHTHALMIC DRUGS AND DEVICES MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 29 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 30 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 31 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 32 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 33 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 34 US: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 35 US: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 36 US: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 37 US: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 38 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 39 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 40 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 41 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 42 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 43 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 44 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 45 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 46 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 47 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 48 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 49 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 50 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 51 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 52 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 53 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 54 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 55 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 56 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 57 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 58 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 59 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 60 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 61 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 62 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 63 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 64 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 65 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 66 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 67 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 68 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 69 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 70 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 71 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 72 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 73 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 74 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 75 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 76 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 77 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 78 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 79 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 80 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 81 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 82 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 83 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 84 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 85 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 86 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 87 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 88 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 89 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 90 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

TABLE 91 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 92 SOUTH KOREA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)

TABLE 93 SOUTH KOREA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 94 SOUTH KOREA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)

T